Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:


UAB Launches New Schizophrenia Studies Targeting Glutamate

One percent of the population in the United States has schizophrenia. Doesn’t sound like much, says University of Alabama at Birmingham psychiatrist Robert McCullumsmith, M.D., until you put it in perspective. In a high school class of 300 for example, three may have schizophrenia. It’s a disease that is not well understood, not well treated and can be devastating.

UAB has received two grants totaling $3.9 million from the National Institutes of Mental Health, one of the National Institutes of Health, in an effort to better understand schizophrenia and look for new targets for therapies. McCullumsmith is the lead investigator on one of the grants. James Meador-Woodruff, M.D., chair of the Department of Psychiatry and Behavioral Neurobiology, heads the other.

The target of both is glutamate, a major neurotransmitter in the brain. The tools are cutting-edge methodologies, including laser capture micro dissection – a device that can isolate specific cells for detailed analysis – and advanced proteomics techniques that study the function and structure of proteins. The goal is to better understand why there are profound deficits in glutamate signaling and processing in the brains of those with schizophrenia.

“We know that there is something wrong with the handling of glutamate in the brains of people with schizophrenia,” says McCullumsmith. “What we don’t know is just what is wrong. Is there too much glutamate? Too little? Is it in the wrong place at the wrong time? These studies will look for those answers, and hopefully come away with new targets in the brain for medications or other therapies.”

Schizophrenia is an especially troubling condition because it usually begins in young adults between the ages of 18 and 25.

“People who previously had demonstrated relatively normal development and are in the midst of going to college, starting a family or beginning a career suddenly have deterioration in function, including social and occupational skill sets,” says Meador-Woodruff. “They typically are unable to work and have a hard time maintaining interpersonal relationships.”

More financial and community resources go toward the care and treatment of schizophrenia than any other medical illness, says McCullumsmith, and it’s an equal opportunity condition, affecting all socioeconomic segments and populations.

There are medications available to treat what are called the “positive” symptoms of schizophrenia. Positive symptoms are manifestations that a patient has that they should not have, such as hearing voices and suffering from delusions and hallucinations. Those medications, some developed more than 50 years ago, have serious side effects. The older ones can cause movement disorders; the newer versions can spur obesity, heart disease and diabetes.

There are no medications that deal with what are called “negative” symptoms – manifestations a patient should have but does not. These include grasping the concept of non-verbal communication, motivation and even understanding the need for good grooming and hygiene.

Meador-Woodruff says there are also cognitive symptoms such as decline in memory, decision making and problem solving. Again, there are no medications to treat these symptoms.

“We need new treatments for schizophrenia,” says McCullumsmith. “People with schizophrenia are often homeless, unemployed and unemployable.”

In both trials, the researchers will compare brain tissue collected from patients with schizophrenia who donated their brains to brain banks, including the Alabama Brain Collection, a tissue repository managed by Rosalinda Roberts, Ph.D., a professor of psychiatry at UAB.

Comparisons made between schizophrenic brains and normal controls may reveal changes in glutamate signaling, uptake or dispersal. Meador-Woodruff’s main focus will be on glutamate receptors on cells, while McCullumsmith’s project will look at the mechanism by which excess glutamate is removed from the brain.

“Schizophrenia is a disease that likely has many causes,” says Meador-Woodruff. “There is strong evidence that glutamate plays an important role in the development of the disease. Hopefully, these studies will help define that role and lead us to a better understanding of how to treat schizophrenia.”

About UAB
Known for its innovative and interdisciplinary approach to education at both the graduate and undergraduate levels, the University of Alabama at Birmingham is the state of Alabama’s largest employer and an internationally renowned research university and academic health center; its professional schools and specialty patient-care programs are consistently ranked among the nation’s top 50. Find more information at and

EDITOR’S NOTE: The University of Alabama at Birmingham (UAB) is a separate, independent institution from the University of Alabama, which is located in Tuscaloosa. Please use University of Alabama at Birmingham on first reference and UAB on second reference.


Bob Shepard | Newswise Science News
Further information:

More articles from Studies and Analyses:

nachricht Rutgers-led innovation could spur faster, cheaper, nano-based manufacturing
14.02.2018 | Rutgers University

nachricht New study from the University of Halle: How climate change alters plant growth
12.01.2018 | Martin-Luther-Universität Halle-Wittenberg

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Locomotion control with photopigments

Researchers from Göttingen University discover additional function of opsins

Animal photoreceptors capture light with photopigments. Researchers from the University of Göttingen have now discovered that these photopigments fulfill an...

Im Focus: Surveying the Arctic: Tracking down carbon particles

Researchers embark on aerial campaign over Northeast Greenland

On 15 March, the AWI research aeroplane Polar 5 will depart for Greenland. Concentrating on the furthest northeast region of the island, an international team...

Im Focus: Unique Insights into the Antarctic Ice Shelf System

Data collected on ocean-ice interactions in the little-researched regions of the far south

The world’s second-largest ice shelf was the destination for a Polarstern expedition that ended in Punta Arenas, Chile on 14th March 2018. Oceanographers from...

Im Focus: ILA 2018: Laser alternative to hexavalent chromium coating

At the 2018 ILA Berlin Air Show from April 25–29, the Fraunhofer Institute for Laser Technology ILT is showcasing extreme high-speed Laser Material Deposition (EHLA): A video documents how for metal components that are highly loaded, EHLA has already proved itself as an alternative to hard chrome plating, which is now allowed only under special conditions.

When the EU restricted the use of hexavalent chromium compounds to special applications requiring authorization, the move prompted a rethink in the surface...

Im Focus: Radar for navigation support from autonomous flying drones

At the ILA Berlin, hall 4, booth 202, Fraunhofer FHR will present two radar sensors for navigation support of drones. The sensors are valuable components in the implementation of autonomous flying drones: they function as obstacle detectors to prevent collisions. Radar sensors also operate reliably in restricted visibility, e.g. in foggy or dusty conditions. Due to their ability to measure distances with high precision, the radar sensors can also be used as altimeters when other sources of information such as barometers or GPS are not available or cannot operate optimally.

Drones play an increasingly important role in the area of logistics and services. Well-known logistic companies place great hope in these compact, aerial...

All Focus news of the innovation-report >>>



Industry & Economy
Event News

Ultrafast Wireless and Chip Design at the DATE Conference in Dresden

16.03.2018 | Event News

International Tinnitus Conference of the Tinnitus Research Initiative in Regensburg

13.03.2018 | Event News

International Virtual Reality Conference “IEEE VR 2018” comes to Reutlingen, Germany

08.03.2018 | Event News

Latest News

Wandering greenhouse gas

16.03.2018 | Earth Sciences

'Frequency combs' ID chemicals within the mid-infrared spectral region

16.03.2018 | Physics and Astronomy

Biologists unravel another mystery of what makes DNA go 'loopy'

16.03.2018 | Life Sciences

Science & Research
Overview of more VideoLinks >>>